Synteract

About:

Synteract®, a Syneos Health® company, is a leading full service CRO focused on the emerging biopharma segment.

Website: https://www.synteract.com/

Twitter/X: Synteract

Top Investors: NorthStar Capital

Description:

Synteract®, a Syneos Health® company, is a leading full service CRO focused on the emerging biopharma segment. The Company’s multidisciplinary teams support biotech and pharmaceutical companies across all phases of drug development, providing deep expertise in oncology, dermatology, general medicine, infectious disease and vaccine, neuroscience, pediatrics, and rare and orphan diseases. Synteract has conducted nearly 4,000 studies on six continents in over 62 countries. To learn more about how Synteract is Bringing clinical trials to lifeTM by transforming insights to action and making therapies a reality, visit synteract.com and connect on LinkedIn and Twitter.